Based on these data, albumin has been proposed to be an immune restorative drug, and albumin supplementation touted as a potential therapeutic strategy by which to restore immune competency and prevent nosocomial infections in patients with end stage liver disease (54). This evidence concerns the gene ALB and nosocomial infection.